ConductScience.org, home
A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
API referenceFor AI assistants

Trial · NCT04771273

Participant flow28

How many started, completed or left each group, period by period.

1 to 20 of 28

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Dose Escalation PeriodSTARTEDSurvodutide 2.4 mg - Planned Maintenance Treatment73
Dose Escalation PeriodSTARTEDSurvodutide 4.8 mg - Planned Maintenance Treatment73
Dose Escalation PeriodSTARTEDSurvodutide 6.0 mg - Planned Maintenance Treatment75
Dose Escalation PeriodSTARTEDPlacebo - Planned Maintenance Treatment74
Dose Escalation PeriodTreated With Trial MedicationSurvodutide 2.4 mg - Planned Maintenance Treatment73
Dose Escalation PeriodTreated With Trial MedicationSurvodutide 4.8 mg - Planned Maintenance Treatment72
Dose Escalation PeriodTreated With Trial MedicationSurvodutide 6.0 mg - Planned Maintenance Treatment74
Dose Escalation PeriodTreated With Trial MedicationPlacebo - Planned Maintenance Treatment74
Dose Escalation PeriodCOMPLETEDSurvodutide 2.4 mg - Planned Maintenance Treatment62
Dose Escalation PeriodCOMPLETEDSurvodutide 4.8 mg - Planned Maintenance Treatment63
Dose Escalation PeriodCOMPLETEDSurvodutide 6.0 mg - Planned Maintenance Treatment57
Dose Escalation PeriodCOMPLETEDPlacebo - Planned Maintenance Treatment68
Dose Escalation PeriodNOT COMPLETEDSurvodutide 2.4 mg - Planned Maintenance Treatment11
Dose Escalation PeriodNOT COMPLETEDSurvodutide 4.8 mg - Planned Maintenance Treatment10
Dose Escalation PeriodNOT COMPLETEDSurvodutide 6.0 mg - Planned Maintenance Treatment18
Dose Escalation PeriodNOT COMPLETEDPlacebo - Planned Maintenance Treatment6
Maintenance PeriodSTARTEDSurvodutide 2.4 mg - Planned Maintenance Treatment62
Maintenance PeriodSTARTEDSurvodutide 4.8 mg - Planned Maintenance Treatment63
Maintenance PeriodSTARTEDSurvodutide 6.0 mg - Planned Maintenance Treatment57
Maintenance PeriodSTARTEDPlacebo - Planned Maintenance Treatment68

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04771273/flow

API referenceFor AI assistants